Reduction of tumor-infiltrating B cells linked to recurrence of NSCLC tumors Read more about Reduction of tumor-infiltrating B cells linked to recurrence of NSCLC tumors
Profiling exhausted T cells using Vectra® Polaris™multiplex immunofluorescence assay in HNSCC Read more about Profiling exhausted T cells using Vectra® Polaris™multiplex immunofluorescence assay in HNSCC
Distinguishing dendritic cell subtypes in the tumor microenvironment using MultiOmyxTM Read more about Distinguishing dendritic cell subtypes in the tumor microenvironment using MultiOmyxTM
Analytical development of the RaDaRTM assay, a highly sensitive and specific assay for the monitoring of minimal residual disease Read more about Analytical development of the RaDaRTM assay, a highly sensitive and specific assay for the monitoring of minimal residual disease
A comprehensive genomic profiling approach to interrogate hematologic malignancies Read more about A comprehensive genomic profiling approach to interrogate hematologic malignancies
Different genomic mutations signatures are associated to specific PD-L1/TMB states on lung cancer with potential value for patients screening for immunotherapy Read more about Different genomic mutations signatures are associated to specific PD-L1/TMB states on lung cancer with potential value for patients screening for immunotherapy
STAG2-mutated AML patients: ASXL1 cohesin binding motif status and mutation landscape Read more about STAG2-mutated AML patients: ASXL1 cohesin binding motif status and mutation landscape
Variant IGH FISH Patterns in Plasma Cell Myeloma Read more about Variant IGH FISH Patterns in Plasma Cell Myeloma
Identification of lung cancer mutational signatures and tumor drivers associated with specific bimodal PD-L1/TMB status Read more about Identification of lung cancer mutational signatures and tumor drivers associated with specific bimodal PD-L1/TMB status
Using multiplexed immunofluorescence to quantitatively analyze myeloid derived suppressor cells (MDSCs) in relation to tertiary lymphoid structures (TLS) in bladder cancer Read more about Using multiplexed immunofluorescence to quantitatively analyze myeloid derived suppressor cells (MDSCs) in relation to tertiary lymphoid structures (TLS) in bladder cancer